1-2 of 2 results for subject:PowderJect
Librarians' tools
- Search time
- 0.198 seconds
- Solr query time
- 0.002 seconds
- Search query
- subject:PowderJect
- We searched for
- subject_t:PowderJect OR subject_t:"Powder Ject" OR subject_t:"PowderJect Pharmaceuticals" OR subject_ses:61760
Subject
X
BSE
Type
House
Session
Year
Department
Member
Primary member
Answering member
Legislative stage
Legislation
Subject
More
BSE (2)
Publisher
To ask the Secretary of State for Health, whether Powderject has guaranteed that the smallpox vaccine to be supplied by them will be free of BSE.
To ask the Secretary of State for Health, whether Powderject has guaranteed that the smallpox vaccine to be supplied by them will be free of BSE.
Asked by
Lord Bellingham
(Conservative)
Answered by
Lord Hutton of Furness
(Labour)
Answering body
Department of Health
Type
Written questions
Status
Answered
Tabled on
2 July 2002
For answer on
24 July 2002
Answered on
24 July 2002
Mr. Bellingham: To ask the Secretary of State for Health whether Powderject has guaranteed that the smallpox vaccine to be supplied
by them will be free of BSE. [67539]
Mr. Hutton: The smallpox vaccine to be supplied by Powderject is not manufactured using bovine cell culture. If a manufacturer
wished to produce smallpox vaccine using virus culture in bovine cells, the appropriate regulatory guidance on cell characterisation
and storage would have to be followed.
European legislation demands that an application for marketing authorisation of a medicinal product in the European Union must
include satisfactory demonstration of compliance with the European Note for Guidance on minimising the risk of transmitting animal
spongiform encephalopathy agents via human and veterinary medicinal products.
Subjects
Contracts; Diseases; Vaccination; BSE; PowderJect; Smallpox
Date
24 July 2002
Reference
67539; 389 c1392-3W;389 c1390-1W
House
House of Commons
To ask the Secretary of State for Health, whether other bidders for the smallpox vaccine awarded to Powderject committed themselves to supply a vaccine that was free of BSE agents.
To ask the Secretary of State for Health, whether other bidders for the smallpox vaccine awarded to Powderject committed themselves to supply a vaccine that was free of BSE agents.
Asked by
Lord Bellingham
(Conservative)
Answered by
Lord Hutton of Furness
(Labour)
Answering body
Department of Health
Type
Written questions
Status
Answered
Tabled on
2 July 2002
For answer on
11 July 2002
Answered on
11 July 2002
Mr. Bellingham: To ask the Secretary of State for Health whether other bidders for the smallpox vaccine awarded to Powderject
committed themselves to supply a vaccine that was free of BSE agents. [67543]
Mr. Hutton: Yes, other bidders for the smallpox vaccine awarded to Powderject committed themselves to supply a vaccine that was free
of bovine spongiform encephalopathy (BSE) agents. European legislation demands that an application for marketing authorisation of a
medicinal product in the European Union must include satisfactory demonstration of compliance with the European note for guidance on
minimising the risk of transmitting animal spongiform encephalopathy agents via human and veterinary medicinal products.
If a manufacturer wishes to produce smallpox vaccine using virus culture in bovine cells, the appropriate regulatory guidance on
cell characterisation and storage would have to be followed.
Subjects
Vaccination; BSE; PowderJect; Smallpox
Date
11 July 2002
Reference
67543; 388 c1206W;388 c1206-7W
House
House of Commons